Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-14T08:29:59.046Z Has data issue: false hasContentIssue false
  • English
  • Français

Controlling Antimicrobial-Resistant Pathogens

Published online by Cambridge University Press:  02 January 2015

William R. Jarvis
William R. Jarvis*
Affiliation:
135 Dune Lane, Hilton Head Island, SC 29928
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 5 , May 2004 , pp. 369 - 372
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

References

1.Smith, TL, Pearson, ML, Wilcox, KR, et al.Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493–501.CrossRefGoogle ScholarPubMed
2.Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR 2002;51:565–567.Google Scholar
3.Centers for Disease Control and Prevention. Public Health Dispatch: vancomycin-resistant Staphylococcus aureus—Pennsylvania, 2002. MMWR 2002;51:902.Google Scholar
4.Richet, HM, Benbachir, M, Brown, D, et al.Are there regional variations in the diagnosis, surveillance, and control of methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2003;24:334–342.CrossRefGoogle ScholarPubMed
5.National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance System report: data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404–421.CrossRefGoogle Scholar
6.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.CrossRefGoogle ScholarPubMed
7.Winston, LG, Bangsberg, DR, Chambers, HF 3rd, et al.Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban hospital. Am J Infect Control 2002;30:400–406.CrossRefGoogle Scholar
8.Rosenberg, J, Jarvis, WR, Abbott, SL, Vugia DJ for the California Emerging Infections Program. Emergence of vancomycin-resistant enterococci in San Francisco Bay area hospitals during 1994 to 1998. Infect Control Hosp Epidemiol 2004;25:408–412.CrossRefGoogle Scholar
9.Stiefel, U, Pultz, NJ, Helfand, MS, Donskey, CJ. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice. Infect Control Hosp Epidemiol 2004;25:373–379.CrossRefGoogle ScholarPubMed
10.Stiefel, U, Paterson, DL, Pultz, NJ, Gordon, SM, Aron, DC, Donskey, CJ. Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers. Infect Control Hosp Epidemiol 2004;25:380–383.CrossRefGoogle ScholarPubMed
11.Christiansen, KJ, Tibbett, PA, Beresford, W, et al.Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004;25:384–390.CrossRefGoogle Scholar
12.Byers, KE, Anglim, AM, Anneski, CJ, et al.A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140–147.CrossRefGoogle ScholarPubMed
13.Ostrowsky, BE, Trick, WE, Sohn, A, et al.Control of vancomycin-resistant enterococcus colonization in healthcare facilities in a region. N Engl J Med 2001;344:1427–1433.CrossRefGoogle Scholar
14.Hachem, R, Graviss, L, Hanna, H, et al.Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 2004;25:391–394.CrossRefGoogle ScholarPubMed
15.Montecalvo, MA, Jarvis, WR, Unan, J, et al.Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269–272.CrossRefGoogle Scholar
16.Montecalvo, MA, Jarvis, WR, Uman, J, et al.Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001;22:437–442.CrossRefGoogle Scholar
17.Boyce, JM, Havill, NL, Kohan, C, Dumigan, DG, Iigi, CE. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2004;25:395401.CrossRefGoogle ScholarPubMed
18.Perencevich, EN, Fishman, DN, Iipsitch, M, Harris, AD, Morris, JG, Smith, D. Projected benefits of active surveillance for vancomycin-resistant enterococci in ICU settings. Clin Infect Dis 2004;38:1108–1115.CrossRefGoogle Scholar